rhDNase as an example of recurrent event analysis

Statistics in Medicine

Volumn 16, Issue 18, 1997, Pages 2029-2047

  Therneau, Terry M ^a   Hamilton, Scott A ^b  

^a MAYO CLINIC   (United States)

^b GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEASE; GAMMA INTERFERON;

ARTICLE; CLINICAL TRIAL; COMPUTER PROGRAM; COVARIANCE; CYSTIC FIBROSIS; HUMAN; INTERMETHOD COMPARISON; SIMULATION; STATISTICAL ANALYSIS; STATISTICAL MODEL;

ADULT; ANALYSIS OF VARIANCE; CHILD; CYSTIC FIBROSIS; DATA COLLECTION; DEOXYRIBONUCLEASE I; DOUBLE-BLIND METHOD; EXPECTORANTS; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; INTERFERON-GAMMA, RECOMBINANT; MATHEMATICAL COMPUTING; MODELS, STATISTICAL; RANDOMIZED CONTROLLED TRIALS; RECOMBINANT PROTEINS; RISK; SOFTWARE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0030763799     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0258(19970930)16:18<2029::AID-SIM637>3.0.CO;2-H     Document Type: Article

References (23)

1. Andersen, P.K. and Gill, R.D. 'Cox's regression model for counting processes: A large sample study', Annals of Statistics, 10, 1100-1120 (1982).
2. Wei, L.J., Lin, D.Y. and Weissfeld, L. 'Regression analysis of multivariate incomplete failure time data by modeling marginal distributions', Journal of the American Statistical Association, 84, 1065-1073 (1989).
3. Prentice, R.L., Williams, B.J. and Peterson, A.V. 'On the regression analysis of multivariate failure time data', Biometrika, 68, 373-389 (1981).
4. Oakes, D.A. 'Frailty models for multiple event times', in Klein, J.P. and Goel, P.K. (eds), Survival Analysis, State of the Art, Kluwer Academic Publishers, Netherlands, 1992, pp. 415.
5. Prentice, R.L. and Cai, J. 'Covariance and survivor function estimation using censored multivariate failure time data', Biometrika, 79, 495-512 (1992).
6. Fleming, T.R. and Harringon, D.P. Counting Processes and Survival Analysis, Wiley, New York, 1991.
7. Therneau, T.M., Grambsch P.M. and Fleming, T.R. 'Martingale based residuals for survival models', Biometrika, 77, 147-160 (1990).
8. Barlow, W.E. and Prentice, R.L. 'Residuals for relative risk regression', Biometrika, 75, 65-74 (1988).
9. Cain, K.C. and Lange, N.T. 'Approximate case influence for the proportional hazards regression model with censored data', Biometrics, 40, 493-499 (1984).
10. Reid, N. and Crépeau, H. 'Influence functions for proportional hazards regression', Biometrika, 72, 1-9 (1985).
11. Crowley, J. and Hu, M. 'Covariance analysis of heart transplant data', Journal of the American Statistical Association, 72, 27-36 (1977).
12. White, H. 'A heteroskedasticity-consistent covariance matrix estimator and a direct test tor heteroskedasticity', Econometrica, 48, 817-830 (1980).
13. White, H. 'Maximum likelihood estimation of misspecified models', Econometrika, 50, 1-25 (1982).
14. Liang, K.L. and Zeger, S.L. 'Longitudinal data analysis using generalized linear models', Biometrika, 73, 13-22 (1986).
15. Lin, D.Y. and Wei, L.J. 'The robust inference for the Cox proportional hazards model', Journal of the American Statistical Association, 84, 1074-1079 (1989).
16. Lee, E.W., Wei, L.J. and Amato D. 'Cox-type regression analysis for large number of small groups of correlated failure time observations', in Klein, J.P. and Goel, P.K. (eds), Survival Analysis, State of the Art, Kluwer Academic Publishers, Netherlands, 1992, pp. 237-247.
17. Lunn, A.D. and McNeil, D.R. Computer-interactive Data Analysis, Wiley, New York, 1991.
18. Laird, N.M. and Olivier, D. 'Covariance analysis of censored survival data using log-linear analysis techniques', Journal of the American Statistical Association, 76, 231-240 (1981).
19. Omori, Y. and Johnson, R.A. 'The influence of random effects on the unconditional hazard rate and survival function', Biometrika, 80, 910-924 (1993).
20. Grambsch, P. and Therneau, T.M. 'Proportional hazards tests and diagnostics based on weighted residuals', Biometrika, 81, 515-526 (1994).
21. Lin, D.Y. 'Cox regression analysis of multivariate failure time data', Statistics in Medicine, 15, 2233-2247 (1994).
22. The International Chronic Granulomatous Disease Cooperative Study Group. 'A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease', New England Journal of Medicine, 324, 509-516 (1991).
23. Fuchs, H.J., Borowitz, D., Christiansen, D., Morris, E., Nash, M., Ramsey, B., Rosenstein, B.J., Smith, A.L. and Wohl, M.E. 'The effect of aerosilozed recombinant human DNase on respiratory exacerbations and pulmonary function in patients with cystic fibrosis', New England Journal of Medicine, 331, 637-642 (1994).